1. Vaginal estrogen products in hormone receptor-positive breast cancer patients on aromatase inhibitor therapy

   • Elisabeth Sulaica
   • Tiffany Han
   • Polly Niravath

   Review 13 May 2016 Pages: 203 - 210

2. Germline RECQL mutations in high risk Chinese breast cancer patients

   • Ava Kwong
   • Vivian Y. Shin
   • Steven A. Narod

   Preclinical study 28 April 2016 Pages: 211 - 215

   

3. Riluzole mediates anti-tumor properties in breast cancer cells independent of metabotropic glutamate receptor-1

   • Cecilia L. Speyer
   • Mahdy A. Nassar
   • David H. Gorski

   Preclinical study 04 May 2016 Pages: 217 - 228

   

4. The need for preoperative baseline arm measurement to accurately quantify breast cancer-related lymphedema

   • Fangdi Sun
   • Melissa N. Skolny
   • Alphonse G. Taghian

   Preclinical study 06 May 2016 Pages: 229 - 240

   

5. Protein disulfide isomerases in the endoplasmic reticulum promote anchorage-independent growth of breast cancer cells

   • Randi Wise
   • Sara Duhachek-Muggy
   • Anna Zolkiewska

   Preclinical study 09 May 2016 Pages: 241 - 252

   

6. ESR1 mutations affect anti-proliferative responses to tamoxifen through enhanced cross-talk with IGF signaling

   • Luca Gelsomino
   • Guowei Gu
   • Suzanne A. W. Fuqua

   Preclinical Study 13 May 2016 Pages: 253 - 265

   

7. A novel subtype classification and risk of breast cancer by histone modification profiling

   • Xiaohua Chen
   • Hanyang Hu
   • Maoguo Shu

   Preclinical study 13 May 2016 Pages: 267 - 279

   

8. The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc⁹⁹ and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies

   • Andreas Karakatsanis
   • Peer Michael Christiansen
   • Leif Bergkvist

   Clinical trial Open access 27 April 2016 Pages: 281 - 294

   

9. Phase II clinical study of eribulin monotherapy in Japanese patients with metastatic breast cancer who had well-defined taxane resistance

   • Kenichi Inoue
   • Tsuyoshi Saito
   • Masafumi Kurosumi

   Clinical Trial Open access 28 April 2016 Pages: 295 - 305

   

10. Efficacy and safety of trastuzumab emtansine (T-DM1) in patients with HER2-positive breast cancer with brain metastases

    • William Jacot
    • Elvire Pons
    • Florence Dalenc

    Clinical Trial 11 May 2016 Pages: 307 - 318

    

11. An international survey of surveillance schemes for unaffected BRCA1 and BRCA2 mutation carriers

    • Dana Madorsky-Feldman
    • Miri Sklair-Levy
    • Eitan Friedman

    Epidemiology 27 April 2016 Pages: 319 - 327

12. Plasma S100P level as a novel prognostic marker of metastatic breast cancer

    • Cike Peng
    • Hongda Chen
    • Barbara Burwinkel

    Epidemiology 04 May 2016 Pages: 329 - 338

    

13. Short-term mortality in older patients treated with adjuvant chemotherapy for early-stage breast cancer

    • Aron S. Rosenstock
    • Xiudong Lei
    • Mariana Chavez-MacGregor

    Epidemiology 04 May 2016 Pages: 339 - 350

14. Risk prediction for local versus regional/metastatic tumors after initial ductal carcinoma in situ diagnosis treated by lumpectomy

    • Annette M. Molinaro
    • Jennette D. Sison
    • Karla Kerlikowske

    Epidemiology 04 May 2016 Pages: 351 - 361

    

15. Optimal Ki67 cut-off for luminal breast cancer prognostic evaluation: a large case series study with a long-term follow-up

    • Sara Bustreo
    • Simona Osella-Abate
    • Isabella Castellano

    Epidemiology Open access 07 May 2016 Pages: 363 - 371

    

16. Post-mastectomy breast reconstruction and its subsequent complications: a comparison between obese and non-obese women with breast cancer

    • Jinhai Huo
    • Benjamin D. Smith
    • Ya-Chen Tina Shih

    Epidemiology 13 May 2016 Pages: 373 - 383

    

17. Real-world outcomes in young women with breast cancer treated with neoadjuvant chemotherapy

    • Cynthia Villarreal-Garza
    • Juan Enrique Bargallo-Rocha
    • Alejandro Mohar

    Epidemiology 17 May 2016 Pages: 385 - 394

    

18. Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia

    • Viswanath Reddy Belum
    • Giselle de Barros Silva
    • Mario E. Lacouture

    Brief Report 05 May 2016 Pages: 395 - 400

    

19. Erratum to: The impact of treatment compliance on fracture risk in women with breast cancer treated with aromatase inhibitors in the United Kingdom

    • Nina Schmidt
    • Louis Jacob
    • Peyman Hadji

    Erratum 10 May 2016 Pages: 401 - 401

20. Erratum: Randomized, blinded trial of vitamin D₃ for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS)

    • Alice C. Shapiro
    • Susan A. Adlis
    • Rachel E. Lerner

    Erratum 11 May 2016 Pages: 403 - 403